A new study has found that prevalence rates of chronic obstructive pulmonary disease varied by occupation.
A new study has found that between 2013 and 2017, out of the 2.4 million working adults in the United States with chronic obstructive pulmonary disease (COPD) who never smoked cigarettes, the highest rates of COPD were found among office and administrative support workers and those who worked in mining and information industries, according to CDC’s Morbidity and Mortality Weekly Report.
An estimated 24% of adults with COPD have never smoked. Among these individuals, 26% to 53% of COPD occurrences can be attributed to a variety of workplace exposures including dust, fumes, gases, vapors, second-hand smoke exposure, and other causes.
CDC analyzed National Health Interview Survey (NHIS) data from 2013 to 2017 to assess industry and occupation-specific COPD prevalence rates among adults 18 or more years old who have never smoked and were employed any time during the past year.
Participants with COPD were identified by a positive response to a series of questions including:
Among approximately 106 million workers who had never smoked, 2.2% had COPD. Prevalence rates of the disease for nonsmokers were:
Individuals with COPD who never smoked missed an average of 14.9 work days per year due to an illness or injury compared to an average of 5.4 missed by individuals who did not have COPD.
Reflecting industry and occupation, highest COPD prevalence rates among workers who never smoked were:
Gender was found to account for differences in COPD prevalence by occupation among nonsmokers. Among men, the highest COPD prevalence rates were:
Among female nonsmokers, the highest COPD prevalence rates by occupation were:
The study also found that women accounted for 66% of all nonsmokers with COPD who were employed within the last year.
Respondents who had smoked 100 or less cigarettes in their lifetime were considered to have never smoked. Those who smoked more than 100 cigarettes were considered to have ever smoked. Respondents self-reported health status at the time of interview, the number of physician office and emergency department visits, and the number of work days lost within the past year due to illness of injury.
NHIS data were collected annually from a nationally representative sample of the United States population through a personal interview. Data collected during 2013 to 2017 were combined to improve the precision and reliability of estimates. Survey response rates ranged from 61.2% in 2013 to 53.0% in 2017. Data on participants’ current industry and occupation were categorized into 21 industry groups and 23 occupation groups.
Researchers analyzed data using SAS version 9.4. Respondents with unknown or missing information for COPD were excluded from the analysis. Statistically significant differences between point estimates were determined by 2-sided t-tests.
The observation of high rates of COPD among workers who never smoked supports the hypothesis that occupational exposures may contribute to the development of COPD. Researchers believe that identifying occupational risk factors, making efforts to reduce adverse workplace exposures, and promoting research to characterize risk factors for COPD are crucial for preventing and reducing COPD among nonsmoking workers.
Reference
Syamlal G, Doney B, Mazurek JM. Chronic obstructive pulmonary disease prevalence among adults who have never smoked, by industry and occupation — United States, 2013—2017 [published online April 5, 2019]. MMWR Morb Mortal Wkly Rep. 2019;68(13):303—307. doi: 10.15585/mmwr.mm6813a2.
A Pulmonologist on Why You Should Think About Respiratory Health and the Lungs
November 16th 2021On this episode of Managed Care Cast, we speak with MeiLan K. Han, MD, MS, the author of a book released this month called Breathing Lessons: A Doctor’s Guide to Lung Health. Han, a pulmonologist, gives an inside tour of the lungs and how they work, zooms out to examine the drivers of poor respiratory health, and addresses policy changes that are needed to improve lung health.
Listen
Interstitial Lung Abnormalities in Patients With COPD Linked to Cancer, Heart Failure Risks
October 23rd 2024Interstitial lung abnormalities (ILAs) in patients with chronic obstructive pulmonary disease (COPD) are linked to lower lung adenocarcinoma rates but higher rates of other cancers and heart failure.
Read More
Opioids, Benzodiazepines Linked to Higher Mortality in Older Patients With COPD
September 30th 2024A study found that opioid use, with or without benzodiazepines, significantly increases long-term mortality risk in patients with chronic obstructive pulmonary disease (COPD) over the age of 60 years.
Read More
FDA Approves Dupilumab as First Biologic Treatment for COPD
September 27th 2024The FDA approved dupilumab today as the first biologic treatment for patients with uncontrolled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype to significantly help reduce exacerbations and improve lung function.
Read More